| |
| |
|
| Insider
Information: |
Thorp Clay |
| Relationship: |
Director |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
80,215 |
|
|
Indirect Shares
|
8,859,224 |
|
|
| Direct
Value |
$56,731 |
|
|
|
Indirect Value
|
$5,666,332 |
|
|
| Total
Shares |
8,939,439 |
|
|
| Total
Value |
$5,723,063 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 24.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-09-25 |
40,522 |
2023-09-25 |
3,545,040 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
10% Owner |
|
0 |
2017-05-16 |
213,114 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
36,693 |
2023-05-19 |
3,545,040 |
Premium* |
|
|
Vigil Neuroscience, Inc. |
VIGL |
Director |
2022-05-17 |
3,000 |
2022-05-17 |
1,556,030 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-03-16 |
4 |
AS |
$6.77 |
$145,453 |
I/I |
(21,485) |
4,057,364 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-04-17 |
4 |
AS |
$7.43 |
$163,460 |
I/I |
(22,000) |
4,035,364 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-04-18 |
4 |
AS |
$7.48 |
$332,523 |
I/I |
(44,455) |
3,990,909 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-04-19 |
4 |
AS |
$7.37 |
$14,961 |
I/I |
(2,030) |
3,988,879 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-05-15 |
4 |
AS |
$8.94 |
$142,513 |
I/I |
(15,941) |
3,972,938 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
10% Owner |
– – • |
2017-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
213,114 |
|
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-05-16 |
4 |
AS |
$8.61 |
$82,174 |
I/I |
(9,544) |
3,963,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-05-17 |
4 |
AS |
$8.39 |
$159,410 |
I/I |
(19,000) |
3,944,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-05-18 |
4 |
AS |
$8.44 |
$75,960 |
I/I |
(9,000) |
3,935,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-05-19 |
4 |
AS |
$8.31 |
$124,650 |
I/I |
(15,000) |
3,920,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-08-07 |
4 |
AS |
$8.02 |
$36,090 |
I/I |
(4,500) |
3,915,894 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-08-08 |
4 |
AS |
$7.98 |
$39,900 |
I/I |
(5,000) |
3,910,894 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-08-09 |
4 |
AS |
$7.30 |
$109,500 |
I/I |
(15,000) |
3,895,894 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-09-13 |
4 |
AS |
$7.49 |
$63,665 |
I/I |
(8,500) |
3,887,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-09-14 |
4 |
AS |
$7.52 |
$45,120 |
I/I |
(6,000) |
3,881,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-09-15 |
4 |
AS |
$7.54 |
$75,400 |
I/I |
(10,000) |
3,871,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-10-03 |
4 |
AS |
$8.64 |
$129,600 |
I/I |
(15,000) |
3,856,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-10-04 |
4 |
AS |
$8.59 |
$120,260 |
I/I |
(14,000) |
3,842,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-10-05 |
4 |
AS |
$8.34 |
$50,040 |
I/I |
(6,000) |
3,836,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-11-14 |
4 |
AS |
$7.02 |
$105,300 |
I/I |
(15,000) |
3,821,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-11-15 |
4 |
AS |
$6.99 |
$104,850 |
I/I |
(15,000) |
3,806,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-11-16 |
4 |
AS |
$6.99 |
$34,950 |
I/I |
(5,000) |
3,801,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-12-05 |
4 |
AS |
$6.37 |
$95,550 |
I/I |
(15,000) |
3,786,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-12-06 |
4 |
AS |
$6.09 |
$91,350 |
I/I |
(15,000) |
3,771,394 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-12-07 |
4 |
AS |
$6.13 |
$30,650 |
I/I |
(5,000) |
3,766,394 |
0 |
- |
|
80 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
